The global leukemia treatment landscape is evolving rapidly as pharmaceutical companies continue to introduce innovative therapies aimed at improving survival rates and reducing treatment-related complications. Growing prevalence of blood cancers, advancements in precision medicine, and increasing adoption of immunotherapies are significantly contributing to the expansion of the leukemia...